ISRAEL ACQUISITIONS CORP Operating Income
ISRAEL ACQUISITIONS CORP (ISRL) reported Operating Income of -$126.56 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- ISRAEL ACQUISITIONS CORP operating income (loss) for the quarter ending 2026-06-30 was -$126.56K.
- ISRAEL ACQUISITIONS CORP operating income (loss) for the quarter ending 2026-03-31 was -$245.32K.
- ISRAEL ACQUISITIONS CORP operating income (loss) for the quarter ending 2025-12-31 was -$252.88K.
- ISRAEL ACQUISITIONS CORP operating income (loss) for the quarter ending 2025-09-30 was -$280.99K.
- ISRAEL ACQUISITIONS CORP operating income (loss) for fiscal 2025 was -$1.16M.
- ISRAEL ACQUISITIONS CORP operating income (loss) for fiscal 2024 was -$1.41M.
- ISRAEL ACQUISITIONS CORP operating income (loss) for fiscal 2023 was -$1.05M.
- ISRAEL ACQUISITIONS CORP operating income (loss) for fiscal 2022 was -$71.94K.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$126.56K 10-Q · filed 2026-08-14 | -$371.88K 10-Q · filed 2026-08-14 | -$624.76K derived: sum of 3 quarters · filed 2026-08-14 | -$905.75K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$245.32K 10-Q · filed 2026-05-15 | -$498.20K derived: sum of 2 quarters · filed 2026-05-15 | -$779.19K derived: sum of 3 quarters · filed 2026-05-15 | -$1.13M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$252.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$533.87K derived: sum of 2 quarters · filed 2026-03-31 | -$882.99K derived: sum of 3 quarters · filed 2026-08-14 | -$1.16M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$280.99K 10-Q · filed 2025-11-14 | -$630.12K derived: sum of 2 quarters · filed 2026-08-14 | -$911.39K 10-Q · filed 2025-11-14 | -$1.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$349.13K 10-Q · filed 2026-08-14 | -$630.40K 10-Q · filed 2026-08-14 | -$880.61K derived: sum of 3 quarters · filed 2026-08-14 | -$1.11M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$281.27K 10-Q · filed 2026-05-15 | -$531.49K derived: sum of 2 quarters · filed 2026-05-15 | -$765.76K derived: sum of 3 quarters · filed 2026-05-15 | -$1.06M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$250.21K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$484.49K derived: sum of 2 quarters · filed 2026-03-31 | -$778.17K derived: sum of 3 quarters · filed 2026-03-31 | -$1.41M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$234.27K 10-Q · filed 2025-11-14 | -$527.95K derived: sum of 2 quarters · filed 2025-11-14 | -$1.16M 10-Q · filed 2025-11-14 | -$1.47M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$293.68K 10-Q · filed 2025-08-13 | -$925.46K 10-Q · filed 2025-08-13 | -$1.24M derived: sum of 3 quarters · filed 2025-08-13 | -$1.43M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$631.77K 10-Q · filed 2025-05-14 | -$946.69K derived: sum of 2 quarters · filed 2025-05-14 | -$1.13M derived: sum of 3 quarters · filed 2025-05-14 | -$1.45M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$314.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$500.62K derived: sum of 2 quarters · filed 2025-03-31 | -$819.38K derived: sum of 3 quarters · filed 2025-03-31 | -$1.05M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$185.71K 10-Q · filed 2024-11-15 | -$504.47K derived: sum of 2 quarters · filed 2024-11-15 | -$731.02K 10-Q · filed 2024-11-15 | -$756.21K derived: sum of 4 quarters · filed 2024-11-15 |
| 2023-06-30 | -$318.76K 10-Q · filed 2024-08-14 | -$545.32K 10-Q · filed 2024-08-14 | -$570.50K derived: sum of 3 quarters · filed 2024-08-14 | -$581.01K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$226.55K 10-Q · filed 2024-05-15 | -$251.74K derived: sum of 2 quarters · filed 2024-05-15 | -$262.25K derived: sum of 3 quarters · filed 2024-05-15 | -$272.52K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$25.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$35.69K derived: sum of 2 quarters · filed 2024-03-28 | -$45.97K derived: sum of 3 quarters · filed 2024-03-28 | -$71.94K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$10.51K 10-Q · filed 2023-11-13 | -$20.79K derived: sum of 2 quarters · filed 2023-11-13 | -$46.76K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$10.28K 10-Q · filed 2023-08-14 | -$36.25K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$25.97K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aimei Health Technology Co., Ltd. (AFJK) | United States | $0.038B | |
| CO2 Energy Transition Corp. (NOEM) | United States | $0.040B | |
| Innventure, Inc. (INV) | United States | $0.068B | -2.99 |
| Origin Investment Corp I (ORIQ) | $0.090B | 13.93 | |
| XFLH Capital Corp (XFLH) | United States | $0.139B | |
| Aldel Financial II Inc. (ALDF) | United States | $0.323B |